These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2509505)

  • 1. Anabolic steroid therapies for growth disorders.
    Rogol AD
    Hosp Pract (Off Ed); 1989 Nov; 24(11):89-92, 97-100, 103-6. PubMed ID: 2509505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current research on recombinant human growth hormone and the related growth factors, IGF-1 and GRF.
    Fryklund L
    Acta Paediatr Scand Suppl; 1986; 325():85-9. PubMed ID: 3109208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic indications in growth retardation].
    Job JC
    Presse Med; 1991 Feb; 20(4):149-51. PubMed ID: 1825869
    [No Abstract]   [Full Text] [Related]  

  • 4. [Taller with growth hormones?].
    Wit JM
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():1-3. PubMed ID: 3137693
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.
    Ross RJ; Rodriguez-Arnao J; Bentham J; Coakley JH
    Intensive Care Med; 1993; 19 Suppl 2():S54-7. PubMed ID: 7508957
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth.
    Isaksson OG; Lindahl A; Nilsson A; Isgaard J
    Endocr Rev; 1987 Nov; 8(4):426-38. PubMed ID: 3319530
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapeutic potential of recombinant human insulin-like growth factor-I.
    Cotterill AM
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):11-5. PubMed ID: 1424187
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of children with slow growth: how much of what for whom?].
    Wit JM
    Ned Tijdschr Geneeskd; 1990 May; 134(18):899-904. PubMed ID: 2111882
    [No Abstract]   [Full Text] [Related]  

  • 9. Interplay of somatostatin and growth hormone-releasing hormone in genesis of episodic growth hormone secretion.
    Tannenbaum GS; Painson JC; Lapointe M; Gurd W; McCarthy GF
    Metabolism; 1990 Sep; 39(9 Suppl 2):35-9. PubMed ID: 1976217
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up and down the growth hormone cascade.
    Clark RG; Robinson IC
    Cytokine Growth Factor Rev; 1996 Jun; 7(1):65-80. PubMed ID: 8864355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.
    Veldhuis JD; Iranmanesh A
    Sleep; 1996 Dec; 19(10 Suppl):S221-4. PubMed ID: 9085516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone releasing factor and somatomedin C production: extrahypothalamic localization and possible functional significance.
    Thorner MO; Vance ML; Evans WS; Ho K; Rogol AD; Blizzard RM; Furlanetto R; Rivier J; Vale W
    Acta Endocrinol Suppl (Copenh); 1986; 276():34-40. PubMed ID: 3092530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anabolic effects of GH/IGF system on bone.
    Kasukawa Y; Miyakoshi N; Mohan S
    Curr Pharm Des; 2004; 10(21):2577-92. PubMed ID: 15320746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short stature in children--diagnostic and therapeutical problems.
    Ranke MB
    Indian J Pediatr; 1991; 58 Suppl 1():3-9. PubMed ID: 1824372
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy with recombinant human insulin-like growth factor I in children with insensitivity to growth hormone and in catabolic conditions.
    Underwood LE; Backeljauw P
    J Intern Med; 1993 Dec; 234(6):571-7. PubMed ID: 8258748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Growth hormone (GH) gene, secretion, and biological activity].
    Okubo Y; Takano K
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():555-60. PubMed ID: 16279700
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone and insulin-like growth factor I in chronic renal failure--pathophysiology and rationale for growth hormone treatment.
    Mehls O; Tönshoff B; Blum WF; Heinrich U; Seidel C
    Acta Paediatr Scand Suppl; 1990; 370():28-34; discussion 35. PubMed ID: 2260455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modern views on the activities of growth hormone].
    Blaim A; Kulesza B; Palińska-cudnoch M
    Pol Tyg Lek; 1976 Oct; 31(40):1737-9. PubMed ID: 790343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Symposium: Pathology and physiology of growth].
    Ann Endocrinol (Paris); 1985; 46(4-5):287-96. PubMed ID: 3837631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.